Megasoft Limited — Board Meeting, 01-07-2025: Outcome of Board Meeting

Megasoft has announced a board meeting approving the proposed sale of its 36.52% stake in Swiss associate Extrovis AG to Refex Life Sciences Pvt. Ltd. The deal is valued at around INR 128.40 Cr (US$15 million), subject to forex movements, with the SPA yet to be executed. This transaction, outside any merger scheme, won't impact Megasoft’s standalone financials but has been reflected proportionately in consolidated results due to Extrovis’s losses. Shareholder approval will be sought via postal ballot before completion. No promoter group involvement in the sale.